Lee's Pharmaceutical Holdings Limited (HKG:0950)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.470
+0.010 (0.68%)
At close: Feb 13, 2026
Market Cap865.59M +20.5%
Revenue (ttm)1.44B +19.8%
Net Income97.81M +55.1%
EPS0.17 +55.1%
Shares Out588.84M
PE Ratio8.85
Forward PEn/a
Dividend0.05 (3.20%)
Ex-Dividend DateSep 12, 2025
Volume725,500
Average Volume780,635
Open1.460
Previous Close1.460
Day's Range1.440 - 1.490
52-Week Range1.190 - 2.700
Beta0.55
RSI38.17
Earnings DateMar 27, 2026

About HKG:0950

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea... [Read more]

Sector Healthcare
Founded 1994
Employees 1,036
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0950
Full Company Profile

Financial Performance

In 2024, HKG:0950's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial Statements